New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises
-
By
-
Elaine Chen
-
Allison DeAngelis
-
Adam Feuerstein
-
June 18, 2026
-
Clinical Scorecard: Promising Advances in Huntington's Disease Treatment and an Evaluation of RFK Jr.'s Health Initiatives
At a Glance
| Category | Detail |
|---|
| Condition | Huntington's Disease |
| Key Mechanisms | Gene therapy targeting the underlying genetic cause of Huntington's disease. |
| Target Population | Individuals living with Huntington's disease. |
| Care Setting | Biotechnology and gene therapy development. |
Key Highlights
- FDA reversed its opposition to a gene therapy for Huntington's disease.
- UniQure is preparing to file for U.S. approval of the gene therapy.
- Discussion includes insights from a Huntington's disease advocate.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Individuals with early stages of Huntington's disease.
Emerging gene therapy options may provide new treatment avenues.
Clinical Best Practices
Related Resources & Content
